Skip to main content

Table 2 Summarised statistical results for antibody staining in BC

From: The role of antibody expression and their association with bladder cancer recurrence: a single-centre prospective clinical-pilot study in 35 patients

Antibody Overall staining pattern in patients’ Bladder tumours (Chi square) Association between antibody expression and cancer grade (Kruskal–Wallis test) Association between antibody expression and cancer stage (Kruskal–Wallis test) Association between antibody expression and cancer recurrence (Mann–Whitney test)
CD31 Increased expression in vascular cells (p < 0.001) Not significant (p = 0.257) Significant (p = 0.002) Not significant (p = 0.69)
Thrombomodulin Reduced/loss of expression (p < 0.010) Not significant (p = 0.827) Not significant (p = 0.039) Not significant (p = 0.89)
HER-2 Increased expression (p < 0.032) Significant (p = 0.003) Significant (p < 0.001) Not significant (p = 0.91)
S100P Increased expression (p < 0.001) Not significant (p = 0.902) Not significant (p = 0.344) Not significant (p = 0.23)
CEACAM-1 Reduced/loss of expression (p < 0.001) Not significant (p = 0.045) Significant (p = 0.005) Not significant (p = 0.65)
COX-2 Increased expression (p < 0.001) Not significant (p = 0.619) Not significant (p = 0.439) Not significant (p = 0.98)
VEGFR-3 Increased expression (p < 0.001) Not significant (p = 0.123) Not significant (p = 0.231) Not significant (p = 0.38)